Group 1 - Tianyuan Group (06119) plans to develop new businesses related to China's health industry and has established a wholly-owned subsidiary in Hong Kong to promote this initiative [1] - The company has appointed Mr. Wu Yu as the general manager of the new subsidiary, who has extensive experience in the medical and management fields [1] - The group aims to diversify its business portfolio and expand revenue sources by exploring new opportunities in the health industry, particularly in response to the aging population and increasing demand for health management in China [1] Group 2 - The Chinese health industry shows significant growth potential, supported by national strategies such as "Healthy China 2030" and the 14th and 15th Five-Year Plans [2] - The government has elevated the development of the health industry to a national strategic priority, providing long-term policy support for areas like innovative drugs, advanced medical devices, and digital health [2] - Continuous reforms in the medical system, health insurance, and pharmaceuticals are enhancing the industry ecosystem and promoting high-quality development, creating substantial market opportunities [2]
天源集团成立附属公司进军医疗保健行业 拟开展与中国大健康产业相关的新业务